Some trials are focusing on drugs that target the immune system, which is affected by different pathways to long covid.

The global pandemic may have officially waned, but for millions around the world, the aftershocks of COVID-19 remain an ...

Low-dose naltrexone (LDN) has been identified as a potential treatment for Long COVID after a Griffith University study, ...

While the Trump administration targets COVID-19-related research, a new report from the ECDC shows the benefits of ...

“Individuals that experience long COVID report a constellation of symptoms, and these symptoms can be cognitive, they can be ...

Among the more unconventional options for treating long COVID, nicotine – delivered via low-dose transdermal patches – has ...

University of Virginia researchers uncover immune system changes linked to lung damage in Long COVID patients, offering hope for personalized treatments to address lingering respiratory complications.

Long COVID remains a public health concern, with the highest disease risk observed in older adults, women, and those with preexisting conditions or severe acute illness.

In most people with mild to moderate COVID, it can last 7–10 days. Symptomatic people can spread the infection to others from ...

Long COVID patients come to his practice complaining ... then we can develop multidisciplinary treatment to focus on all aspects of the individual," he added. "I think patients and our medical ...